EMJ GOLD - European Medical Journal

Pharma News, Views & Analysis

Filter Advertise With Us

FDA removes hurdle to CAR T-cell therapies

The body is eliminating of Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed CAR T-cell therapies.

Scientists crack the code for keeping lab-grown tissue alive

FluidForm Bio’s 3D bioprinting tech keeps lab-grown cells alive five times deeper using vascular-like gelatin scaffolds.

Illustration of signed papers

UK enacts new clinical trial regulations

The UK government has formally signed into law new clinical trial regulations, designed to modernise operations across the country.

Lightening bolt on grey background

New tool supercharges lipid nanoparticle analysis

CloudSpec speeds up lipid nanoparticle analysis, cutting lab times from hours to seconds for gene therapy and vaccine research.

British government buildings

UK government unveils Health Data Research Service

The UK government has announced a significant new initiative to accelerate drug discovery and improve patient care in the country.

Pharma must balance creativity and trust in 2025, says VML

Pharma must balance creativity with transparency to rebuild trust in 2025. VML Health’s report reveals key trends shaping expectations.

Novo Nordisk announces significant leadership reshuffle

Novo Nordisk has announced major leadership changes, with EVP Camilla Sylvest departing and Ludovic Helfgott taking on an expanded role.

The word spotlight on a blue background

Spotlight: March 2025

From the latest news impacting the UK’s NHS to large industry acquisitions, March brought a range of impactful news.

Spoonful of technology: Jan-March 2025

Discover the latest pharma innovations, from needle-free vaccines to NHS data access and interactive case studies in medical education.

Loading posts...

« Previous 1 … 3 4 5 6 7 … 30 Next »